Often collaborating with its expansive international network, Herbert Smith Freehills Kramer LLP‘s team stands out for its handling of patent revocation and enforcement actions, in addition to issues surrounding patent validity. Frédéric Chevallier is recommended for his strong focus on patent litigation and regulatory issues within the pharma industry, often representing global pharma corporations.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Kernmandanten
- Sanofi
- Millennium Pharmaceuticals, Inc. (Takeda)
- Roche
- Foundation Medicine
- Janssen
Highlight-Mandate
- Advising Sanofi on four infringement actions started before the Unified Patent Court in relation to one of its innovative products, Jevtana®, for the treatment of prostate cancer (cabazitaxel).
- Representing Millennium Pharmaceuticals Inc., Takeda Pharmaceuticals and its exclusive licensee Janssen in the enforcement strategy of their patents, protecting their blockbuster bortezomib product against generic entry.
Anwält*innen
Praxisleitung
Frédéric Chevallier